Consultants Forum Advertise
Subscribe
Close

  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Subscribe Now
Renew

Area Development - Site Selection, Facility Planning and Workforce Development

Swiss-Based Hoffmann-La Roche Limited Expands Mississauga, Ontario, Canada, Operations

12/12/2024
Swizz-based Hoffmann-La Roche Limited (Roche), a global diagnostics and pharmaceuticals company, plans to expand its operations in Mississauga, Ontario, Canada. The more than $92 million project is expected to create up to 250 jobs over five years.

The new Global Informatics Hub will be located at Roche Canada’s existing headquarters.

"Transformative technologies like artificial intelligence are reshaping healthcare, offering new solutions for improving access and altering how companies operate in the sector. The expansion of our Informatics division right here in Ontario will enable us to leverage unique approaches and technologies to enable data-driven decision-making, allowing us to analyze data much more quickly and enhance various aspects of healthcare,” said Brian Mereweather, Mississauga Informatics Site Lead, Roche Canada.

To support the project the Invest Ontario Fund will provide a $3.5 million CAD grant.

“As one of the largest life sciences jurisdictions in North America, Ontario is a prime location for domestic and international biomanufacturers looking to invest and bring their innovative ideas from lab to market. The new jobs in Roche’s Global Informatics Hub are a welcome addition to our province’s growing life sciences ecosystem and represent a vote of confidence in our highly-skilled workforce and research environment. We look forward to seeing this partnership grow and bring economic growth and good-paying jobs to Mississauga,” Minister of Economic Development, Job Creation and Trade Hon. Vic Fedeli noted.

“This was Roche Canada’s first partnership with Invest Ontario and we are thrilled to champion Ontario’s talent together. Roche’s continued commitment signifies their confidence in Ontario’s life sciences ecosystem to contribute to a global business,” Jennifer Block, Invest Ontario Interim CEO added.

Exclusive Research